Microstructural investigation of nimesulide-crospovidone composites by X-ray diffraction and thermal analysis

被引:15
作者
Bergese, P
Bontempi, E
Colombo, I
Gervasoni, D
Depero, LE
机构
[1] Univ Brescia, INSTM, I-25123 Brescia, Italy
[2] Univ Brescia, Struct Chem Lab, I-25123 Brescia, Italy
[3] Eurand Int SpA, Phys Pharm, I-20060 Milan, Italy
关键词
microstructure; nimesulide; polymorphism;
D O I
10.1016/S0266-3538(03)00078-2
中图分类号
TB33 [复合材料];
学科分类号
摘要
Dispersion into crospovidone is a widely employed method for enhancing the solubility of poorly water-soluble drugs, since the 3D polymeric network stabilizes the active substance in molecular clusters and nano-crystalline phases. Nimesulide loaded into crospovidone shows two polymorphic modifications: the native material (form I) and the phase reported on ICDD and CSD databases (form II). Microstructure and polymorphism of the composites have been investigated as they affect the drug dissolution rate and in vivo absorption kinetics (i.e. the bio-availability of the drug from its dosage form). Differential scanning calorimetry (DSC) showed that the lower melting form (form II) is metastable. X-ray diffraction (XRD) evidenced that the embedded crystalline phases are made up of nano-crystallites and that no significant difference on their size exists. Quantitative analysis of the composites turned out to be a challenge with both XRD (preferred orientation effects and form I crystalline structure unknown) and DSC (high nimesulide-crospovidone reactivity). Nevertheless, the results suggest a direct correlation between crospovidone and form II weight fractions. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1197 / 1201
页数:5
相关论文
共 21 条
[1]   Micro X-ray diffraction on capillary powder samples: a novel and effective technique for overcoming preferred orientation [J].
Bergese, P ;
Bontempi, E ;
Colombo, I ;
Depero, LE .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2001, 34 :663-665
[2]  
BERGESE P, 2001, P 7 EUR C ADV MAT PR
[3]  
Brittain H.G., 1999, Polymorphism in Pharmaceutical Solids, V95
[4]  
Bruker AXS, 2000, TOPAS V2 0 GEN PROF
[5]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[6]   INFLUENCE OF POLYMER CHARACTERISTICS ON DRUG LOADING INTO CROSPOVIDONE [J].
CARLI, F ;
COLOMBO, I ;
MAGAROTTO, L ;
MOTTA, A ;
TORRICELLI, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :115-124
[7]   A FUNDAMENTAL PARAMETERS APPROACH TO X-RAY LINE-PROFILE FITTING [J].
CHEARY, RW ;
COELHO, A .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1992, 25 (pt 2) :109-121
[8]   NIMESULIDE [J].
DUPONT, L ;
PIROTTE, B ;
MASEREEL, B ;
DELARGE, J ;
GECZY, J .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1995, 51 (pt 3) :507-509
[9]   Drug release from an ensemble of swellable crosslinked polymer particles [J].
Grassi, M ;
Colombo, I ;
Lapasin, R .
JOURNAL OF CONTROLLED RELEASE, 2000, 68 (01) :97-113
[10]   PHARMACEUTICAL APPLICATIONS OF POLYMORPHISM [J].
HALEBLIAN, J ;
MCCRONE, W .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (08) :911-+